Litigation Details for Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
Docket | ⤷ Subscribe | Date Filed | 2024-07-01 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | Assigned To | Colm Felix Connolly | |
Jury Demand | Referred To | ||
Patents | 10,335,462; 6,268,343; 8,129,343; 8,536,122 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc.
Biologic Drugs cited in Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc.
Details for Novo Nordisk Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2024-07-01 | 1 | Exhibit A - B | U.S. Patent Jul. 2, 2019 Sheet 1 of 6 US 10,335,462 B2 …PageID #: 86 U.S. Patent Jul. 2, 2019 Sheet 3 of 6 US 10,335,462 B2 ….S. Patent Jul. 2, 2019 Sheet 6 of 6 US 10,335,462 B2 … US 10,335,462 B2 Jensen …of 6 US 10,335,462 B2 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |